Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_assertion type Assertion NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_head.
- NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_assertion description "[For the characterization of the tumor cell lines we a) determined population doubling times, b) assessed morphological features by light and electron microscopy, c) investigated the expression of typical markers by immunohistochemistry, including various intermediate filaments and surface antigens, d) compared these findings with expression patterns in the respective original tumor specimens, e) evaluated p53 mutations in tumor specimens and cell lines, f) performed chromosome analysis, g) investigated the tumorigenicity in athymic mice, and h) tested the formation of both tumor and mixed tumor-fibroblast multicellular spheroids.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_provenance.
- NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_assertion evidence source_evidence_literature NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_provenance.
- NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_assertion SIO_000772 10628319 NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_provenance.
- NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_assertion wasDerivedFrom befree-20150227 NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_provenance.
- NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_assertion wasGeneratedBy ECO_0000203 NP750753.RAVAyXwgVnOO7XHSWKe65puIn9qa0w5dkuHPvh1CbjDOk130_provenance.